Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1999 Nov;54(11):995–1003. doi: 10.1136/thx.54.11.995

An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting

M R Molken 1, B Roos 1, J A Van Noord 1
PMCID: PMC1745382  PMID: 10525558

Abstract

BACKGROUND—The Chronic Respiratory Questionnaire (CRQ) and the St George's Respiratory Questionnaire (SGRQ) are the two most widely used quality of life questionnaires in chronic obstructive pulmonary disease (COPD). A study was undertaken to compare directly the self-administered version of the CRQ and the SGRQ with respect to feasibility, internal consistency, validity, and sensitivity to changes resulting from bronchodilator therapy.
METHODS—One hundred and forty four patients with moderate or severe COPD were randomly assigned to receive three months of treatment with either salmeterol, salmeterol + ipratropium bromide, or placebo. Quality of life was measured at baseline and after 12 weeks of treatment.
RESULTS—The proportions of missing values per patient were low for both questionnaires (0.54% for the CRQ and 2% for the SGRQ). The internal consistency was good for both questionnaires (Cronbach's α coefficients ⩾0.84 for the CRQ and ⩾0.76 for the SGRQ). Factor analysis confirmed the original domain structure of the CRQ but not of the SGRQ. Correlations with forced expiratory volume in one second (FEV1) % predicted and peak expiratory flow rate (PEFR) were low for both questionnaires but better for the SGRQ than for the CRQ. The ability to discriminate between subjects with different levels of FEV1 was somewhat better for the SGRQ. The correlations with symptom scores were comparable for both questionnaires. Cross sectionally, the scores of the two questionnaires were moderately to highly correlated (coefficients ranged from 0.35 to 0.72). Longitudinally, these correlations were lower (coefficients ranged from 0.17 to 0.54) but were still significant. The CRQ total and emotions score and the SGRQ symptoms score were the most responsive to change. The SGRQ symptoms domain was the only domain where the improvement in patients receiving combination treatment crossed the threshold for clinical relevance.
CONCLUSIONS—Since this analysis of reliability, validity, and responsiveness to change did not clearly favour one instrument above the other, the choice between the CRQ and the SGRQ can be based on other considerations such as the required sample size or the availability of reference values.



Full Text

The Full Text of this article is available as a PDF (101.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson A., Ström K., Brodin H., Alton M., Boman G., Jakobsson P., Lindberg A., Uddenfeldt M., Walter H., Levin L. A. Domiciliary liquid oxygen versus concentrator treatment in chronic hypoxaemia: a cost-utility analysis. Eur Respir J. 1998 Dec;12(6):1284–1289. doi: 10.1183/09031936.98.12061284. [DOI] [PubMed] [Google Scholar]
  2. Bouchet C., Guillemin F., Hoang Thi T. H., Cornette A., Briançon S. Validation du questionnaire St Georges pour mesurer la qualité de vie chez les insuffisants respiratoires chroniques. Rev Mal Respir. 1996;13(1):43–46. [PubMed] [Google Scholar]
  3. Ferrer M., Alonso J., Prieto L., Plaza V., Monsó E., Marrades R., Aguar M. C., Khalaf A., Antó J. M. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J. 1996 Jun;9(6):1160–1166. doi: 10.1183/09031936.96.09061160. [DOI] [PubMed] [Google Scholar]
  4. Goldstein R. S., Gort E. H., Stubbing D., Avendano M. A., Guyatt G. H. Randomised controlled trial of respiratory rehabilitation. Lancet. 1994 Nov 19;344(8934):1394–1397. doi: 10.1016/s0140-6736(94)90568-1. [DOI] [PubMed] [Google Scholar]
  5. Guyatt G. H., Berman L. B., Townsend M., Pugsley S. O., Chambers L. W. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987 Oct;42(10):773–778. doi: 10.1136/thx.42.10.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Guyatt G. H., Townsend M., Keller J. L., Singer J. Should study subjects see their previous responses: data from a randomized control trial. J Clin Epidemiol. 1989;42(9):913–920. doi: 10.1016/0895-4356(89)90105-4. [DOI] [PubMed] [Google Scholar]
  7. Guyatt G. H., Townsend M., Keller J., Singer J., Nogradi S. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med. 1989 Jul;83(4):293–297. doi: 10.1016/s0954-6111(89)80199-4. [DOI] [PubMed] [Google Scholar]
  8. Güell R., Casan P., Sangenís M., Santís J., Morante F., Borras J. M., Guyatt G. Traducción española y validación de un cuestionario de calidad de vida en pacientes con enfermedad pulmonar obstructiva crónica. Arch Bronconeumol. 1995 May;31(5):202–210. doi: 10.1016/s0300-2896(15)30925-x. [DOI] [PubMed] [Google Scholar]
  9. Hajiro T., Nishimura K., Tsukino M., Ikeda A., Koyama H., Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):785–790. doi: 10.1164/ajrccm.157.3.9703055. [DOI] [PubMed] [Google Scholar]
  10. Harper R., Brazier J. E., Waterhouse J. C., Walters S. J., Jones N. M., Howard P. Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax. 1997 Oct;52(10):879–887. doi: 10.1136/thx.52.10.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jaeschke R., Guyatt G. H., Willan A., Cook D., Harper S., Morris J., Ramsdale H., Haddon R., Newhouse M. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation. Thorax. 1994 May;49(5):479–484. doi: 10.1136/thx.49.5.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jaeschke R., Singer J., Guyatt G. H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989 Dec;10(4):407–415. doi: 10.1016/0197-2456(89)90005-6. [DOI] [PubMed] [Google Scholar]
  13. Jones P. W., Bosh T. K. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med. 1997 Apr;155(4):1283–1289. doi: 10.1164/ajrccm.155.4.9105068. [DOI] [PubMed] [Google Scholar]
  14. Jones P. W., Quirk F. H., Baveystock C. M., Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992 Jun;145(6):1321–1327. doi: 10.1164/ajrccm/145.6.1321. [DOI] [PubMed] [Google Scholar]
  15. Jones P. W., Quirk F. H., Baveystock C. M. The St George's Respiratory Questionnaire. Respir Med. 1991 Sep;85 (Suppl B):25–37. doi: 10.1016/s0954-6111(06)80166-6. [DOI] [PubMed] [Google Scholar]
  16. Juniper E. F., Guyatt G. H., Streiner D. L., King D. R. Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol. 1997 Mar;50(3):233–238. doi: 10.1016/s0895-4356(96)00377-0. [DOI] [PubMed] [Google Scholar]
  17. Ketelaars C. A., Abu-Saad H. H., Schlösser M. A., Mostert R., Wouters E. F. Long-term outcome of pulmonary rehabilitation in patients with COPD. Chest. 1997 Aug;112(2):363–369. doi: 10.1378/chest.112.2.363. [DOI] [PubMed] [Google Scholar]
  18. Lacasse Y., Wong E., Guyatt G. H., King D., Cook D. J., Goldstein R. S. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet. 1996 Oct 26;348(9035):1115–1119. doi: 10.1016/S0140-6736(96)04201-8. [DOI] [PubMed] [Google Scholar]
  19. Okubadejo A. A., O'Shea L., Jones P. W., Wedzicha J. A. Home assessment of activities of daily living in patients with severe chronic obstructive pulmonary disease on long-term oxygen therapy. Eur Respir J. 1997 Jul;10(7):1572–1575. doi: 10.1183/09031936.97.10071572. [DOI] [PubMed] [Google Scholar]
  20. Quirk F. H., Baveystock C. M., Wilson R., Jones P. W. Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries. Eur Respir J. 1991 Feb;4(2):167–171. [PubMed] [Google Scholar]
  21. Redelmeier D. A., Guyatt G. H., Goldstein R. S. Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol. 1996 Nov;49(11):1215–1219. doi: 10.1016/s0895-4356(96)00206-5. [DOI] [PubMed] [Google Scholar]
  22. Siafakas N. M., Vermeire P., Pride N. B., Paoletti P., Gibson J., Howard P., Yernault J. C., Decramer M., Higenbottam T., Postma D. S. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995 Aug;8(8):1398–1420. doi: 10.1183/09031936.95.08081398. [DOI] [PubMed] [Google Scholar]
  23. Wijkstra P. J., Ten Vergert E. M., van Altena R., Otten V., Kraan J., Postma D. S., Koëter G. H. Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease. Thorax. 1995 Aug;50(8):824–828. doi: 10.1136/thx.50.8.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wijkstra P. J., TenVergert E. M., Van Altena R., Otten V., Postma D. S., Kraan J., Koëter G. H. Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax. 1994 May;49(5):465–467. doi: 10.1136/thx.49.5.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wright J. G. The minimal important difference: who's to say what is important? J Clin Epidemiol. 1996 Nov;49(11):1221–1222. doi: 10.1016/s0895-4356(96)00207-7. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES